Ventricular remodeling in heart failure: a credible surrogate endpoint.
Marvin A
MA
Konstam
James E
JE
Udelson
Inder S
IS
Anand
Jay N
JN
Cohn
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D015415:Biomarkers; D065128:Endothelin Receptor Antagonists; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology*; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications; D020257:Ventricular Remodeling / Q000187:drug effects
D000806:Angiotensin-Converting Enzyme Inhibitors; D015415:Biomarkers; D065128:Endothelin Receptor Antagonists; D005343:Fibrinolytic Agents